|
Session 50
Poster Abstracts
Cellular Defenses and Restriction Factors
Monday, 1:30 - 3:30 pm
Poster Hall |
| 200 |
Peptide Inhibitors of in vitro Binding of HIV-1 Vif to Human APOBEC3G
John Donahue*, R D'Aquila, D Haas, and C Aiken
Vanderbilt Univ Sch of Med, Nashville, TN, US |
| 201 |
Patterns in Retrovirus-primate Host Co-evolution
Millán Ortiz*1, G Bleiber1, R Martinez1, V Goldschmidt1, H Kaessmann2, and A Telenti1
1Inst of Microbiology, Univ of Lausanne, Switzerland and 2Ctr for Integrative Genomics, Univ of Lausanne, Switzerland |
| 202 |
Endogenous APOBEC3G Protein Expression in Normal CD4 T Cells Is Strongly Up-regulated after their Activation and mostly Translocates to the Nucleus
Harold Oliva*1, M Rodríguez-García1, N Climent1, F García1, M Plana1, J Miró1, J Gatell1, N Navaratnam2, and T Gallart1
1Hosp Clin, Univ of Barcelona, Spain and 2MRC, Hammersmith Hosp Campus, London, UK |
| 203 |
APOBEC3G Expression Is Restricted to Neurons in the Brains of Pig-tailed Macaques
M Sarah Hill*, L Gomez, J M Miller, and E Stephens
Univ of Kansas Med Ctr, Kansas City, US |
| 204 |
TRIM5a Restriction of FIV and HIV-1: Lentivirus and Cell Line Dependence
Dyana Saenz* and E Poeschla
Mayo Clin Coll of Med, Rochester, MN, US |
| 205 |
Variation in the Antiretroviral Protein TRIM5a in Humans
Valérie Goldschmidt*1, M Ortiz1, M May2, R Martinez1, H Kaessmann3, G Bleiber1, and A Telenti1
1Inst of Microbiology, Lausanne, Switzerland; 2Dept of Social Med, Bristol, UK; and 3Ctr for Integrative Genomics, Lausanne, Switzerland |
| 206 |
Evolution of Cyclophilin A and TRIMCyp Retrotransposition in New World Primates
I Ribeiro1, A Menezes2, M Moreira2, C Bonvicino2, H Seuánez1,2, and Marcelo A. Soares*1
1Fed Univ of Rio de Janeiro, Brazil and 2Natl Inst of Cancer, Rio de Janeiro, Brazil |
| 207 |
The Effect of Proteasome Inhibitors on TRIM5a Expression, Turnover and Cell Biology
Xiaolu Wu*1, J Anderson2, E Campbell2, A Joseph2, and T Hope2
1Univ of Illinois Coll of Med, Chicago, US and 2Northwestern Univ Med Sch, Chicago, IL, US |
| 208 |
Inhibition of HIV-1 Infectivity by the Human Cellular Prolyl Isomerase Pin1
T Uchida1 and Andrew Saphire*2
1Ctr for Interdisciplinary Res, Tohoku Univ, Aramaki Aza, Aoba, Sendai, Japan and 2Scripps Res Inst, La Jolla, CA, US |
| 209 |
DBR1 siRNA Inhibition of HIV-1 Replication Indicates an RNA Lariat Intermediate during Minus-strand Transfer
Ying Ye*, J De Leon, V Sung, and D Camerini
Univ of California, Irvine, US |
| 210 |
HIV Infection Is Suppressed by G9, a Novel Innate Effector Protein
Annapurna Vyakarnam*, R Alvarez, and D King
King's Coll London Sch of Med, London, UK |
211
 |
Deletion Mapping of the GB Virus C Nonstructural Protein 5A Identifies a 69 Amino Acid Region Required for Inhibition of HIV Replication in Jurkat Cells
Jinhua Xiang*, J McLinden, Q Chang, T Kaufman, and J Stapleton
VAMC and Univ of Iowa, Iowa City, US |
|
